27 February 2020 4 Min Read
Bayer may have to sell assets to pay for Roundup cancer suits
Bayer is facing 48,600 US plaintiffs with its shares down 31% since the $63bn takeover of Monsanto, which brought it the herbicide Roundup
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In